Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Implementation of precision medicine in healthcare—A European perspective
Albrecht Stenzinger, Ejner K. Moltzen, Eva C. Winkler, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 4, pp. 437-454
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries
Vincent D. de Jager, Wim Timens, Arnaud Bayle, et al.
The Lancet Regional Health - Europe (2024) Vol. 38, pp. 100838-100838
Open Access | Times Cited: 24
Future perspective for the application of predictive biomarker testing in advanced stage non-small cell lung cancer
Vincent D. de Jager, Wim Timens, Arnaud Bayle, et al.
The Lancet Regional Health - Europe (2024) Vol. 38, pp. 100839-100839
Open Access | Times Cited: 24
Health informatics to enhance the healthcare industry's culture: An extensive analysis of its features, contributions, applications and limitations
Mohd Javaid, Abid Haleem, Ravi Pratap Singh
Informatics and Health (2024) Vol. 1, Iss. 2, pp. 123-148
Open Access | Times Cited: 13
The Advent of Molecular Targeted Therapies Against Cancer. Toward Multi‐Targeting Drugs Through Materials Engineering: A Possible Future Scenario
Marianna Puzzo, Marzia De Santo, Catia Morelli, et al.
Small Science (2024) Vol. 4, Iss. 8
Open Access | Times Cited: 7
Benefits for children with suspected cancer from routine whole-genome sequencing
Angus Hodder, Sarah M. Leiter, Jonathan Kennedy, et al.
Nature Medicine (2024) Vol. 30, Iss. 7, pp. 1905-1912
Open Access | Times Cited: 7
Precision Medicine—Are We There Yet? A Narrative Review of Precision Medicine’s Applicability in Primary Care
William Evans, Eric M. Meslin, Joe Kai, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 418-418
Open Access | Times Cited: 6
High‐throughput molecular assays for inclusion in personalised oncology trials – State‐of‐the‐art and beyond
Anders Edsjö, Hege G. Russnes, Janne Lehtiö, et al.
Journal of Internal Medicine (2024) Vol. 295, Iss. 6, pp. 785-803
Open Access | Times Cited: 5
Precision prevention in worksite health–A scoping review on research trends and gaps
Filip Mess, Simon Blaschke, Teresa Sofie Schick, et al.
PLoS ONE (2024) Vol. 19, Iss. 6, pp. e0304951-e0304951
Open Access | Times Cited: 5
PFMG2025–integrating genomic medicine into the national healthcare system in France
Caroline Abadie, Aldja Abderrahmane, Ouarda Abdous, et al.
The Lancet Regional Health - Europe (2025) Vol. 50, pp. 101183-101183
Open Access
Digital Health Technologies in Pediatric Infectious Disease and the Perspective of Patients and Healthcare Professionals: A Review
Alen Sam Saji, Aqsa Komel, Muhammad Hamza Khan, et al.
Health Science Reports (2025) Vol. 8, Iss. 3
Open Access
The expanding global genomics landscape: Converging priorities from national genomics programs
Caitlin Howley, Matilda Haas, Wadha A. Al Muftah, et al.
The American Journal of Human Genetics (2025)
Open Access
Holistic precision wellness: Paving the way for next‐generation precision medicine (ngPM) with AI, biomedical informatics, and clinical medicine
Sawsan Mohammed, M. Walid Qoronfleh, Ahmet Acar, et al.
FASEB BioAdvances (2025)
Open Access
Current and emerging sequencing-based tools for precision cancer medicine
Anders Edsjö, David Gisselsson, Johan Staaf, et al.
Molecular Aspects of Medicine (2024) Vol. 96, pp. 101250-101250
Closed Access | Times Cited: 3
Das Verbundprojekt „Personalisierte Medizin für die Onkologie“ (PM4Onco) als Teil der Medizininformatik-Initiative (MII)
Patrick Metzger, Melanie Boerries
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2024) Vol. 67, Iss. 6, pp. 668-675
Open Access | Times Cited: 3
Bridging the gap in precision medicine: TranSYS training programme for next-generation scientists
Lara Andreoli, Catalina Berca, Sonja Katz, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Diabetes and obesity: leveraging heterogeneity for precision medicine
Paul W. Franks, Jennifer L Sargent
European Heart Journal (2024)
Open Access | Times Cited: 3
Genetic counselling legislation and practice in cancer in EU Member States
J. Matt McCrary, Els Van Valckenborgh, Hélène A. Poirel, et al.
European Journal of Public Health (2024) Vol. 34, Iss. 4, pp. 666-675
Open Access | Times Cited: 2
A long and winding road: culture change on data sharing in exposomics
Robert O. Wright, Konstantinos C. Makris, Pantelis Natsiavas, et al.
Exposome (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Pioneering the implementation of a precision oncology strategy in Portugal: the Precision Oncology Platform trial
Beatrice Mainoli, Joana Assis, José Dinis, et al.
Acta Oncologica (2024) Vol. 63, pp. 482-486
Open Access | Times Cited: 1
Evolving and Improving the Sustainability of Molecular Tumor Boards: The Value and Challenges
Marius Bartels, Benoist Chibaudel, Rodrigo Dienstmann, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2888-2888
Open Access | Times Cited: 1
Standardization through education of molecular pathology: a spotlight on the European Masters in Molecular Pathology
Marius Ilié, Vivien Lake, Enrique de Álava, et al.
Virchows Archiv (2024) Vol. 485, Iss. 5, pp. 761-775
Closed Access | Times Cited: 1
From Strategy to Synergy: Paving Ontario’s Proactive Path in Precision Medicine with Collaboration and Visionary Leadership
Abbas Zavar, Razieh Poorandy
Studies in health technology and informatics (2024)
Open Access | Times Cited: 1
Whole genome sequencing as a ticket to cancer treatment in the Netherlands: Are inequalities in access to molecular diagnostics unfair?
Jilles Smids, Charlotte H C Bomhof, Maarten IJzerman, et al.
Journal of Cancer Policy (2024) Vol. 41, pp. 100492-100492
Closed Access
Harmonization of tumor mutation burden testing with comprehensive genomic profiling assays: an IQN Path initiative
Riziero Esposito Abate, Raffaella Pasquale, Alessandra Sacco, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 2, pp. e007800-e007800
Open Access
ZNAČAJ PRECIZNE MEDICINE I FARMAKOGENOMIKE U PREVENTIVNOJ PEDIJATRIJI
Ivana Kavečan, Nataša Nikolić, Đerđi Erdeš-Kavečan, et al.
Deleted Journal (2024), pp. 060-064
Open Access
Page 1 - Next Page

Scroll to top